RPG Life Sciences (RPGLS), part of the RPG Group, engaged in manufacturing and marketing of pharmaceutical products, has received an approval for the sale and transfer of its Biotech Unit, as a going concern on a slump sale basis to Intas Pharmaceuticals. The board of directors at its meeting held on May 26, 2016 has approved for the same.
RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.
